Paracoccidioidomycosis in Patients with Lymphoma and Review of Published Literature
- 186 Downloads
This paper describes four new cases of lymphomas, two Hodgkin lymphomas and two non-Hodgkin lymphomas in patients with paracoccidioidomycosis. All had mycosis diagnosed before lymphomas with Paracoccidioides brasiliensis demonstrated in several lymph nodes, as seen in the disseminated form of the disease. When lymphoma was diagnosed, one patient was under regular paracoccidioidomycosis treatment and in clinic-serological remission for this disease, another was under regular treatment but with clinic-serological mycosis activity, one had abandoned paracoccidioidomycosis treatment 6 years earlier, and the other had not yet received any kind of antifungal drugs. Three patients received treatment for lymphomas with one remaining in remission until now, one achieving tumor remission which relapsed years later, and one having only residual lymphoma in bone marrow for a decade but clinically well. All three experienced paracoccidioidomycosis clinical remission, however, serology became negative just in one. Similar previously described cases were reviewed: five Hodgkin lymphomas, three non-Hodgkin lymphomas, and one described only as “lymphoma” without specifying type; a summary of their findings is presented. Finally, there is also a brief discussion on the possible pathophysiological mechanisms involved in the concomitance of these two disorders.
KeywordsLymphoma Cancer Neoplasia Paracoccidioidomycosis Paracoccidioides brasiliensis
This work was partially supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo), Process Number: 2012/04850-6.
Conflict of interest
- 1.Lacaz CS, Faria JL, Moura RAA. Blastomicose Sul-Americana Associada à Moléstia de Hodgkin. Hospital. 1948;34(3):25–42.Google Scholar
- 2.Altério DL, Del Negro G. Blastomicose Sul-Americana Associada à Moléstia de Hodgkin. Hospital. 1960;57(1):95–102.Google Scholar
- 3.Severo LC, Palombarini BC, Utz E, Braun SN. Paracoccidioidomicose pulmonar resultante de reativação de lesão quiescente, em paciente imunossuprimido. J Bras Pneumol. 1980;6(1):21–2.Google Scholar
- 5.Conceição YTM. Paracoccidioidomicose e Câncer. Frequência da associação em estudo de necrópsias. [Dissertação de Mestrado] São Paulo, Faculdade de Medicina da Universidade de São Paulo; 1996. 102p. (Cited by Shikanai-Yasuda et al. ). Google Scholar
- 6.Campos SV, Campos AF, Branco MCT, Kono ASG, Freitas VL, Rivitti EA, Shikanai-Yasuda MA. Estudo retrospectivo dos casos de paracoccidioidomicose e neoplasias do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Congresso da Sociedade Paulista de Infectologia; 2004, Santos, Brazil. (Cited by Shikanai-Yasuda et al. ).Google Scholar
- 7.Leão RC, Mendes E. Paracoccidioidomycosis, neoplasia and associated infections. Allergol Immunopathol. 1980;8:185–8.Google Scholar
- 14.Pontes HA, Guimarães DM, Pontes FS, Paiva HB, Pinto LC, de Freitas Silva BS, Dos Santos Pinto D Jr. Kaposi sarcoma and paracoccidioidomycosis in the same fragment of oral mucosa biopsy: a rare association in human immunodeficiency virus-positive patient. A case report. Diagn Microbiol Infect Dis. 2011;69(2):196–9.CrossRefPubMedGoogle Scholar
- 23.Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 439.Google Scholar
- 24.Kumar V, Abbas AK, Fausto N, editors. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders; 2005. Cap. 7, Neoplasia; pp. 269–342.Google Scholar